myEANM account
Log into your myEANM account or create a new one.
This webinar will provide the evidence for PET imaging in medullary thyroid cancer according to the literature and the to international recommendations with a focus on the available radiopharmaceuticals and perspectives.
Learning Objectives: The aim of this webinar is to understand and to learn the correct use of PET radiopharmaceuticals for staging and restaging medullary thyroid cancer.
Gustave Roussy – Villejuif, France
University of Zürich – Zurich, Switzerland
ENDOCAN-TUTHYREF network – Villejuif, France
Log into your myEANM account or create a new one.
Access the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations
Enter the course store, make your selection and check out.
Find your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE
The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org